2603003315
  • Open Access
  • Editorial

Translational Insights: A Paradigm Reversal in Translational Research

  • Yang Liang 1,2,*,   
  • Francesco M. Marincola 3,4,*

Received: 09 Mar 2026 | Accepted: 09 Mar 2026 | Published: 16 Mar 2026

References 

  • 1.

    Marincola, F.M. Translational Medicine: A Two-Way Road. J. Transl. Med. 2003, 1, 1.

  • 2.

    Obermeyer, Z. Bedside to Bench—AI and the New Science of Medicine. New Engl. J. Med. 2025, 393, 2287–2289.

  • 3.

    DiMasi, J.A.; Hansen, R.W.; Grabowski, H.G. The Price of Innovation: New Estimates of Drug Development Costs. J. Health Econ. 2003, 22, 151–185.

  • 4.

    Morris, Z.S.; Wooding, S.; Grant, J. The Answer Is 17 Years, What Is the Question: Understanding Time Lags in Translational Research. J. R. Soc. Med. 2011, 104, 510–520.

  • 5.

    Schellens, J.H.M. Phase 0 (Zero) Clinical Trials: More Than Zero Benefit? Eur. J. Cancer 2009, 45, 728–729.

Share this article:
How to Cite
Liang, Y.; Marincola, F. M. Translational Insights: A Paradigm Reversal in Translational Research. Translational Insights 2026, 1 (1), 1.
RIS
BibTex
Copyright & License
article copyright Image
Copyright (c) 2026 by the authors.